COX and 5-LOX metabolic products such as prostanoids and leukotrienes are implicated in degenerative diseases such as cancer progression and may represent important targets for cancer chemoprevention or treatment [41]. This evidence concerns the gene ALOX5 and neurodegenerative disease.